Cite
MLA Citation
L Zhang et al.. “A randomized phase III study evaluating the efficacy of single-dose NEPA, a fixed antiemetic combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy (HEC).” Annals of oncology, vol. 29, 2018, pp. 452–458. http://access.bl.uk/ark:/81055/vdc_100095487119.0x00003d